CG-549 Tablet Pharmacokinetics Study

计划入组 24 人 · 首次发布于 2022 年 5 月 26 日

Pharmacokinetics and Safety of 'CG-745 IV' and 'CG-750' in Healthy Male Adults

计划入组 24 人 · 首次发布于 2022 年 4 月 26 日

A Phase II Trial of CG 8020 and CG 2505 in Patients With Nonresectable or Metastatic Pancreatic Cancer

计划入组 50 人 · 首次发布于 2005 年 10 月 28 日

CG-8020+CG-2505

CG'806

CG-400549

C₁₉H₂₀N₂O₂S

CG Pharmaceuticals, Inc.

United States

CG Oncology, Inc.

United States

INVITAE CORPORATION

United States

Huons Acquires 31.53% Stake in PanGen Biotech for $10.4 Million to Advance Biopharmaceutical CDMO Business

Cretostimogene Shows Promise in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

CureGene's Novel Antiplatelet Therapy CG-0255 Receives Clinical Trial Approval in China